Testing effectiveness (Phase 2)Looking for participantsNCT04276870
What this trial is testing
Orphan Indications for CD19 Redirected Autologous T Cells
Who this might be right for
Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALLInfants With Very High Risk KMT2A B-ALLPatients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation
Stephan Grupp MD PhD 133